Pin-point Base Editing Platform Licensing Options

FAQs

• What's the difference between discovery and therapeutic licenses?

  Discovery licenses for the Pin-point base editing platform are designed for early-stage research, including target discovery, platform evaluation, and exploratory studies.

  Therapeutic licenses for the Pin-point platform support programs advancing toward clinical and commercial development, providing the rights needed for therapeutic applications.

• Can I upgrade from a discovery to therapeutic license later?

  Yes. Partners can begin with a discovery license to evaluate the Pin-point base editing platform and generate key data, then transition to a therapeutic license as their program advances.

• Do I need a therapeutic license for preclinical research?

  It depends on your intent. If your work is purely exploratory or research-focused, a discovery license is typically sufficient. If your program is being developed with the goal of advancing toward clinical or commercial use, a therapeutic license may be more appropriate. Our team can help determine the best fit based on your plans.

• How quickly can I get started?

  We aim to provide fast, straightforward access, especially for discovery-stage work. Timelines can vary depending on the type of agreement and scope, but our goal is to help you get started as efficiently as possible.

• What reagent supply options are available?

  We offer RUO reagent supply to support both discovery and therapeutic work, including access to selected configurations of the Pin-point system.

  Supply approaches can be tailored based on your program needs, stage, and scale. If we can’t directly supply exactly what you need, we can connect you to a network of trusted partners who can.

• What kind of support do you provide?

  We tailor our support based on your goals and how you prefer to work.

  This can range from straightforward access to platform use, to more hands-on support such as experimental design guidance, workflow optimization, and technology transfer for advanced programs.

• Are there other ways to access the Pin-point platform besides licensing?

  Yes. In addition to licensing, we offer flexible engagement options such as evaluation agreements, material transfer agreements (MTAs), and collaborative research opportunities.

• Can I publish research data generated using the Pin-point platform?

  Yes. We support publication of research findings generated using the Pin-point platform, helping scientific communication and dissemination.